Financhill
Buy
72

LVS Quote, Financials, Valuation and Earnings

Last price:
$61.88
Seasonality move :
4.61%
Day range:
$61.20 - $63.50
52-week range:
$30.18 - $70.45
Dividend yield:
1.63%
P/E ratio:
27.72x
P/S ratio:
3.53x
P/B ratio:
26.44x
Volume:
8.7M
Avg. volume:
4.9M
1-year change:
24.1%
Market cap:
$41.5B
Revenue:
$11.3B
EPS (TTM):
$2.22
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Revenue $2.9B $4.2B $4.1B $10.4B $11.3B
Revenue Growth (YoY) -78.6% 44.01% -2.93% 152.36% 8.93%
 
Cost of Revenues $3.1B $3.7B $3.5B $6.5B $7.1B
Gross Profit -$176M $567M $614M $3.9B $4.2B
Gross Profit Margin -5.99% 13.39% 14.94% 37.61% 36.76%
 
R&D Expenses $18M $109M $143M $205M $228M
Selling, General & Admin $1B $1.2B $1.4B $1.1B $1.2B
Other Inc / (Exp) -$73M -$214M -$31M -$50M -$54M
Operating Expenses $1.1B $1.2B $1.4B $1.5B $1.7B
Operating Income -$1.3B -$643M -$770M $2.4B $2.5B
 
Net Interest Expenses $523M $621M $702M $818M $727M
EBT. Incl. Unusual Items -$1.9B -$1.5B -$1.4B $1.8B $2B
Earnings of Discontinued Ops. -$243M $193M $2.9B -- --
Income Tax Expense $24M -$5M $154M $344M $208M
Net Income to Company -$1.9B -$1.5B -$1.5B $1.4B $1.8B
 
Minority Interest in Earnings -$458M -$315M -$475M $210M $306M
Net Income to Common Excl Extra Items -$1.9B -$1.5B -$1.5B $1.4B $1.8B
 
Basic EPS (Cont. Ops) -$2.21 -$1.26 -$1.34 $1.60 $1.97
Diluted EPS (Cont. Ops) -$2.21 -$1.26 -$1.34 $1.60 $1.96
Weighted Average Basic Share $764M $764M $764M $763M $735M
Weighted Average Diluted Share $764M $764M $764M $765M $737M
 
EBITDA -$304M $398M $266M $3.7B $3.9B
EBIT -$1.3B -$643M -$770M $2.4B $2.5B
 
Revenue (Reported) $2.9B $4.2B $4.1B $10.4B $11.3B
Operating Income (Reported) -$1.3B -$643M -$770M $2.4B $2.5B
Operating Income (Adjusted) -$1.3B -$643M -$770M $2.4B $2.5B
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Revenue $857M $1B $2.8B $2.7B $3.3B
Revenue Growth (YoY) 92.15% 17.27% 178.11% -4.04% 24.2%
 
Cost of Revenues $846M $837M $1.7B $1.8B $2.1B
Gross Profit $11M $168M $1.1B $930M $1.3B
Gross Profit Margin 1.28% 16.72% 38.68% 34.68% 38.13%
 
R&D Expenses $13M $26M $44M $55M --
Selling, General & Admin $314M $331M $290M $293M $308M
Other Inc / (Exp) -$159M -$4M -$3M -$4M --
Operating Expenses $317M $339M $386M $411M $476M
Operating Income -$306M -$171M $695M $519M $794M
 
Net Interest Expenses $157M $183M $200M $179M $187M
EBT. Incl. Unusual Items -$621M -$320M $571M $403M $582M
Earnings of Discontinued Ops. $99M -$1M -- -- --
Income Tax Expense -$27M $60M $122M $50M $91M
Net Income to Company -$594M -$380M $449M $353M $491M
 
Minority Interest in Earnings -$127M -$142M $69M $78M $72M
Net Income to Common Excl Extra Items -$594M -$380M $449M $353M $491M
 
Basic EPS (Cont. Ops) -$0.48 -$0.31 $0.50 $0.38 $0.61
Diluted EPS (Cont. Ops) -$0.48 -$0.31 $0.50 $0.38 $0.61
Weighted Average Basic Share $764M $764M $764M $730M $682M
Weighted Average Diluted Share $764M $764M $766M $731M $685M
 
EBITDA -$44M $89M $1B $872M $1.2B
EBIT -$306M -$171M $695M $519M $794M
 
Revenue (Reported) $857M $1B $2.8B $2.7B $3.3B
Operating Income (Reported) -$306M -$171M $695M $519M $794M
Operating Income (Adjusted) -$306M -$171M $695M $519M $794M
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Revenue $4.2B $4B $8.6B $11.3B $12.3B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $3.7B $3.4B $5.6B $7.1B $7.7B
Gross Profit $579M $557M $3B $4.2B $4.6B
Gross Profit Margin -- -- -- -- --
 
R&D Expenses $59M $158M $175M $234M --
Selling, General & Admin $1.2B $1.3B $1.4B $1.1B $1.2B
Other Inc / (Exp) -$215M -$73M -$35M -$33M --
Operating Expenses $1.2B $1.3B $1.5B $1.7B $1.8B
Operating Income -$621M -$732M $1.5B $2.6B $2.8B
 
Net Interest Expenses $616M $653M $829M $737M $735M
EBT. Incl. Unusual Items -$1.4B -$1.4B $896M $2.1B $2.1B
Earnings of Discontinued Ops. $2M $3B -$5M -- --
Income Tax Expense $9M $186M $203M $262M $313M
Net Income to Company -$1.5B -$1.6B $693M $1.8B $1.8B
 
Minority Interest in Earnings -$318M -$444M $18M $325M $254M
Net Income to Common Excl Extra Items -$1.5B -$1.6B $693M $1.8B $1.8B
 
Basic EPS (Cont. Ops) -$1.49 -$1.29 $0.88 $2.02 $2.22
Diluted EPS (Cont. Ops) -$1.49 -$1.29 $0.88 $2.01 $2.22
Weighted Average Basic Share
Weighted Average Diluted Share
 
EBITDA $406M $314M $2.6B $4B $4.4B
EBIT -$621M -$732M $1.5B $2.6B $2.8B
 
Revenue (Reported) $4.2B $4B $8.6B $11.3B $12.3B
Operating Income (Reported) -$621M -$732M $1.5B $2.6B $2.8B
Operating Income (Adjusted) -$621M -$732M $1.5B $2.6B $2.8B
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Revenue $3.2B $3B $7.5B $8.4B $9.4B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $2.8B $2.6B $4.7B $5.3B $5.8B
Gross Profit $428M $418M $2.8B $3.1B $3.6B
Gross Profit Margin -- -- -- -- --
 
R&D Expenses $59M $108M $140M $169M $138M
Selling, General & Admin $937M $1B $1.1B $847M $873M
Other Inc / (Exp) -$189M -$48M -$52M -$35M -$56M
Operating Expenses $946M $1B $1.2B $1.2B $1.3B
Operating Income -$518M -$607M $1.6B $1.9B $2.2B
 
Net Interest Expenses $469M $501M $628M $547M $555M
EBT. Incl. Unusual Items -$1.2B -$1.1B $1.2B $1.5B $1.7B
Earnings of Discontinued Ops. $75M $2.9B -- -- --
Income Tax Expense -$19M $172M $221M $139M $244M
Net Income to Company -$1.2B -$1.3B $962M $1.4B $1.4B
 
Minority Interest in Earnings -$241M -$370M $123M $238M $186M
Net Income to Common Excl Extra Items -$1.2B -$1.3B $962M $1.4B $1.4B
 
Basic EPS (Cont. Ops) -$1.10 -$1.13 $1.10 $1.51 $1.77
Diluted EPS (Cont. Ops) -$1.10 -$1.13 $1.09 $1.51 $1.77
Weighted Average Basic Share $2.3B $2.3B $2.3B $2.2B $2.1B
Weighted Average Diluted Share $2.3B $2.3B $2.3B $2.2B $2.1B
 
EBITDA $257M $173M $2.5B $2.9B $3.4B
EBIT -$518M -$607M $1.6B $1.9B $2.2B
 
Revenue (Reported) $3.2B $3B $7.5B $8.4B $9.4B
Operating Income (Reported) -$518M -$607M $1.6B $1.9B $2.2B
Operating Income (Adjusted) -$518M -$607M $1.6B $1.9B $2.2B
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Cash and Equivalents $2.1B $1.9B $6.3B $5.1B $3.7B
Short Term Investments -- -- -- -- --
Accounts Receivable, Net $252M $202M $267M $484M $417M
Inventory $22M $22M $28M $38M $41M
Prepaid Expenses -- -- -- -- --
Other Current Assets $113M $113M $138M $150M $182M
Total Current Assets $5.7B $5.5B $6.7B $5.8B $4.3B
 
Property Plant And Equipment $12.3B $11.9B $11.5B $11.5B $12B
Long-Term Investments -- -- $1.3B $1.3B $1.4B
Goodwill -- -- $10M $103M $102M
Other Intangibles $25M $19M $54M $495M $443M
Other Long-Term Assets $221M $217M $356M $400M $450M
Total Assets $20.8B $20.1B $22B $21.8B $20.7B
 
Accounts Payable $89M $77M $89M $167M $164M
Accrued Expenses $825M $721M $853M $1B $1.1B
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations -- -- -- -- --
Other Current Liabilities $755M $821M -- -- --
Total Current Liabilities $2.8B $2.6B $3.9B $4.4B $5.8B
 
Long-Term Debt $14.1B $14.9B $14.1B $12.4B $10.8B
Capital Leases -- -- -- -- --
Total Liabilities $17.3B $17.8B $18.4B $17.7B $17.5B
 
Common Stock $1M $1M $1M $1M $1M
Other Common Equity Adj $29M -$22M -$7M $27M -$58M
Common Equity $3B $2B $3.9B $4.1B $2.9B
Total Preferred Equity -- -- -- -- --
Minority Interest, Total $565M $252M -$225M -$14M $276M
Total Equity $3.5B $2.2B $3.7B $4.1B $3.2B
 
Total Liabilities and Equity $20.8B $20.1B $22B $21.8B $20.7B
Cash and Short Terms $2.1B $1.9B $6.3B $5.1B $3.7B
Total Debt $14.2B $14.9B $16.1B $14.3B $13.9B
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Cash and Equivalents $1.7B $5.8B $5.6B $4.2B $3.4B
Short Term Investments -- -- -- -- --
Accounts Receivable, Net $167M $210M $390M $413M $548M
Inventory $22M $23M $35M $41M $45M
Prepaid Expenses -- -- -- -- --
Other Current Assets $124M $138M $173M $163M --
Total Current Assets $5.2B $6.2B $6.1B $4.8B $4.2B
 
Property Plant And Equipment $11.9B $11.3B $11.6B $12.1B $11.9B
Long-Term Investments -- $1.5B $1.3B $1.4B $1.4B
Goodwill -- -- $102M -- --
Other Intangibles -- -- $507M -- --
Other Long-Term Assets $223M $509M $388M $426M --
Total Assets $19.9B $21.5B $22.1B $21.4B $21.5B
 
Accounts Payable $74M $91M $150M $139M $168M
Accrued Expenses $1.3B $1.3B $1.8B $1.9B --
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations -- -- -- -- --
Other Current Liabilities $827M -- -- -- --
Total Current Liabilities $2.5B $3.4B $4.1B $5.4B $4.7B
 
Long-Term Debt $14.5B $13.8B $12.6B $11.3B $13.9B
Capital Leases -- -- -- -- --
Total Liabilities $17.5B $17.7B $17.7B $17.7B $19.6B
 
Common Stock $1M $1M $1M $1M $1M
Other Common Equity Adj -$32M -$148M -$57M $84M --
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total $327M -$119M -$101M $221M $296M
Total Equity $2.4B $3.8B $4.5B $3.6B $1.9B
 
Total Liabilities and Equity $19.9B $21.5B $22.1B $21.4B $21.5B
Cash and Short Terms $1.7B $5.8B $5.6B $4.2B $3.4B
Total Debt $14.5B $15.3B $14.4B $14B $15.8B
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Net Income to Stockholders -$1.9B -$1.5B -$1.5B $1.4B $1.8B
Depreciation & Amoritzation $997M $1B $1B $1.3B $1.4B
Stock-Based Compensation $22M $22M $39M $44M $55M
Change in Accounts Receivable $339M $43M -$78M -$217M $43M
Change in Inventories -- -- -- -- --
Cash From Operations -$1.2B -$243M -$944M $3.2B $3.1B
 
Capital Expenditures $1.2B $839M $780M $1.3B $1.6B
Cash Acquisitions -- -- -- -- --
Cash From Investing -$1.2B -$816M -$721M -$1.3B -$1.6B
 
Dividends Paid (Ex Special Dividend) $911M -- -- $305M $590M
Special Dividend Paid
Long-Term Debt Issued $1.9B $2.7B $1.2B -- $1.7B
Long-Term Debt Repaid -$467M -$2B -$66M -$2.1B -$2.1B
Repurchase of Common Stock -- -- -- $505M $1.8B
Other Financing Activities -$31M -$38M -$1M -$281M -$335M
Cash From Financing $355M $863M $6.2B -$3.2B -$3B
 
Beginning Cash (CF) $2.1B $1.9B $6.3B $5.1B $3.7B
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -$2.1B -$212M $4.5B -$1.2B -$1.5B
Ending Cash (CF) -$31M $1.6B $10.8B $3.9B $2.2B
 
Levered Free Cash Flow -$2.4B -$1.1B -$1.7B $1.9B $1.6B
Period Ending 2021-12-31 2022-12-31 2023-12-31 2024-12-31 2025-12-31
Net Income to Stockholders -$315M -$269M $469M $392M --
Depreciation & Amoritzation $266M $256M $363M $376M --
Stock-Based Compensation $7M $9M $11M $13M --
Change in Accounts Receivable -$29M -$50M -$88M -$26M --
Change in Inventories -- -- -- -- --
Cash From Operations $102M -$104M $1B $876M --
 
Capital Expenditures $194M $172M $329M $550M --
Cash Acquisitions -- -- -- -- --
Cash From Investing -$180M -$122M -$329M -$550M --
 
Dividends Paid (Ex Special Dividend) -- -- $152M $145M --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued $251M $500M -- -- --
Long-Term Debt Repaid -$15M -$16M -$266M -$95M --
Repurchase of Common Stock -- -- $505M $450M --
Other Financing Activities -$2M $9M -$223M -$129M --
Cash From Financing $301M $482M -$1.2B -$840M --
 
Beginning Cash (CF) $1.9B $6.3B $5.1B $3.7B --
Foreign Exchange Rate Adjustment $1M $55M $32M -$44M --
Additions / Reductions $224M $311M -$469M -$558M --
Ending Cash (CF) $2.1B $6.7B $4.7B $3B --
 
Levered Free Cash Flow -$92M -$276M $677M $326M --
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Net Income to Stockholders -$1.5B -$1.6B $693M $1.8B $1.8B
Depreciation & Amoritzation $1B $1B $1.2B $1.4B $1.5B
Stock-Based Compensation $20M $37M $42M $53M $52M
Change in Accounts Receivable $88M -$57M -$179M -$19M -$181M
Change in Inventories -- -- -- -- --
Cash From Operations -$297M -$738M $2.1B $3.3B $2.5B
 
Capital Expenditures $874M $802M $1.1B $1.4B $1.5B
Cash Acquisitions -- -- -- -- $475M
Cash From Investing -$860M -$779M -$1B -$1.4B -$2B
 
Dividends Paid (Ex Special Dividend) -- -- $153M $597M $809M
Special Dividend Paid
Long-Term Debt Issued $2.5B $951M -- $1.7B --
Long-Term Debt Repaid -$2B -$65M -$1.8B -$2.2B --
Repurchase of Common Stock -- -- -- $1.8B $2.2B
Other Financing Activities -$37M -$12M -$49M -$429M --
Cash From Financing $475M $6B -$1.5B -$3.3B -$1.4B
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -$697M $4.4B -$427M -$1.4B -$855M
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow -$1.2B -$1.5B $985M $1.9B $975M
Period Ending 2021-12-31 2022-12-31 2023-12-31 2024-12-31 2025-12-31
Net Income to Stockholders -$1.5B -$1.5B $1.4B $1.8B $1.4B
Depreciation & Amoritzation $1B $1B $1.3B $1.4B $1.2B
Stock-Based Compensation $22M $39M $44M $55M $39M
Change in Accounts Receivable $43M -$78M -$217M $43M -$155M
Change in Inventories -- -- -- -- --
Cash From Operations -$243M -$944M $3.2B $3.1B $1.6B
 
Capital Expenditures $839M $780M $1.3B $1.6B $969M
Cash Acquisitions -- -- -- -- $475M
Cash From Investing -$816M -$721M -$1.3B -$1.6B -$1.4B
 
Dividends Paid (Ex Special Dividend) -- -- $305M $590M $664M
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued $2.7B $1.2B -- $1.7B $6.8B
Long-Term Debt Repaid -$2B -$66M -$2.1B -$2.1B -$4.9B
Repurchase of Common Stock -- -- $505M $1.8B $1.7B
Other Financing Activities -$38M -$1M -$281M -$335M -$464M
Cash From Financing $863M $6.2B -$3.2B -$3B -$516M
 
Beginning Cash (CF) $7.7B $25.1B $23B $17.5B $9.8B
Foreign Exchange Rate Adjustment -$16M $22M $8M -$19M $27M
Additions / Reductions -$212M $4.5B -$1.2B -$1.5B -$297M
Ending Cash (CF) $7.5B $29.6B $21.8B $16.1B $9.6B
 
Levered Free Cash Flow -$1.1B -$1.7B $1.9B $1.6B $649M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Did Stan Druckenmiller Sell Broadcom Stock?
Why Did Stan Druckenmiller Sell Broadcom Stock?

In Q3, legendary macro investor Stan Druckenmiller sold his entire…

Why Is CoreWeave Stock Down So Much?
Why Is CoreWeave Stock Down So Much?

AI cloud computing business CoreWeave (NASDAQ:CRWV) has been through a…

Why Did Stan Druckenmiller Buy MercadoLibre Stock?
Why Did Stan Druckenmiller Buy MercadoLibre Stock?

In Q3, billionaire Stan Druckenmiller bought about 4,620 shares of…

Stock Ideas

Buy
59
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 64x

Buy
65
Is GOOG Stock a Buy?

Market Cap: $3.9T
P/E Ratio: 40x

Buy
51
Is GOOGL Stock a Buy?

Market Cap: $3.9T
P/E Ratio: 40x

Alerts

Buy
70
RGC alert for Jan 8

Regencell Bioscience Holdings Ltd. [RGC] is down 21.5% over the past day.

Buy
64
RVMD alert for Jan 8

Revolution Medicines, Inc. [RVMD] is up 4.61% over the past day.

Sell
38
CRNX alert for Jan 8

Crinetics Pharmaceuticals, Inc. [CRNX] is down 0.23% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock